Polyglutamine (polyQ) diseases, such as Huntington's disease and Machado-Joseph disease (MJD), are caused by gain of toxic function of abnormally expanded polyQ tracts. Here, we show that expanded polyQ of ataxin-3 (Q79C), a gene that causes MJD, stimulates Ku70 acetylation, which in turn dissociates the proapoptotic protein Bax from Ku70, thereby promoting Bax activation and subsequent cell death. The Q79C-induced cell death was significantly blocked by Ku70 or Bax-inhibiting peptides (BIPs) designed from Ku70. Furthermore, expression of SIRT1 deacetylase and the addition of a SIRT1 agonist, resveratrol, reduced Q79C toxicity. In contrast, mimicking acetylation of Ku70 abolished the ability of Ku70 to suppress Q79C toxicity. These results indicate that Bax and Ku70 acetylation play important roles in Q79C-induced cell death, and that BIP may be useful in the development of therapeutics for polyQ diseases.
Nine inherited neurodegenerative disorders with expanded polyglutamine (polyQ) are caused by mutations in different genes, but they likely share the common pathology in which expanded polyQ gains toxic functions. 1 The molecular mechanism of neuronal toxicity of polyQ remains enigmatic. Recent findings suggest that the intracellular aggregation of polyQ causes cellular stress responses that trigger neuronal cell death. 1 It is hypothesized that polyQ aggregation suppresses neuronal transcriptional activity by sequestering histone acetyltransferases (HAT) from chromosomes and thus polyQ causes neuronal cell death. [2] [3] [4] Bax is a proapoptotic member of Bcl-2 family proteins that plays a key role in programmed cell death in neurons. 5, 6 Recently, mutant huntingtin with expanded polyQ was shown to activate p53 and increase the expression level of Bax. 7 Based on these previous findings, we became interested in examining the role of Bax in polyQ-induced cell death. Recently, we developed a series of cytoprotective membrane-permeable pentapeptides that rescue cells from Baxmediated cell death. These peptides are named Bax-inhibiting peptides (BIPs) and were designed from the Bax binding domain of Ku70. [8] [9] [10] Ku70 is a multifunctional protein playing roles in DNA repair and cell survival. 11 Ku70 has been shown to inhibit Bax-mediated cell death by binding Bax in the cytosol. [12] [13] [14] The present study demonstrates that BIP can rescue cells from polyQ toxicity, and that polyQ promotes Bax-mediated cell death by inducing Ku70 acetylation that activates Bax.
Results
BIP suppresses Q79C-induced cell death. BIPs consisting of five amino acids (e.g. VPMLK and VPTLK) were used in this study. A mutated peptide (i.e. IPMIK) that does not bind Bax but retains cell permeability was also used in this study as a negative control (NC). For the investigation of polyQ toxicity, we used the C-terminal, truncated fragment of the Machado-Joseph disease 1 (MJD1) gene product, ataxin-3, which includes an expanded polyQ stretch (79 glutamine repeats, Q79C). 15, 16 As a negative control, ataxin-3 C-terminus with 22 or 35 glutamine repeats (Q22C and Q35C, respectively) was used. 15, 16 BIP readily suppressed Q79C-induced cell death in a neuroblastoma cell line (Neuro2a) (Figure 1a and b) and in a human embryonic kidney cell line (HEK293T) (Figure 2a ). Although these cell lines incorporated BIP very efficiently, 9 the primary cultured rat cortical neurons showed very low uptake of BIP. To study whether BIP can suppress polyQ-induced cell death in primary cortical neurons, we utilized the protein transduction domain of the human immunodeficiency virus (HIV) trans-activator (TAT) 17 to enhance cell permeability of BIP. PolyQ was expressed by an adenovirus vector. 16 We confirmed that TAT-BIP efficiently entered primary cortical neurons (Supplementary Figure 1) , and it inhibited polyQinduced cell death in these cells (Figure 1c) . To confirm the role of Bax in polyQ-induced cell death, we employed small interference RNA (siRNA) targeting Bax mRNA (Figure 1d The siRNA significantly inhibited Q79C-induced cell death (Figure 1e ). Furthermore, we examined the cytotoxicity of polyQ in a Bax-deficient cell line, DU145 (human prostate cancer cell line).
18 Q79C did not show significant toxicity in DU145 cells, although Q79C induced cell death if Bax expression was restored (Figure 1f) . These results suggest that Bax is a key mediator of Q79C-induced cell death.
BIP suppresses Q79C-induced nuclear fragmentation and cytoplasmic vacuolation. Next, we examined the effect of a pan-caspase inhibitor on Q79C-induced cell death, because Bax activates the caspases resulting in apoptosis. 6 Unexpectedly, the pan-caspase inhibitor, z-VADfmk, did not show a significant cytoprotective effect against Q79C toxicity when cellular viability was examined by Trypan blue exclusion (Figure 2a and b) and lactate dehydrogenase (LDH) release from the cells into the medium (data not shown). To further determine the role of caspase in Q79C-induced cell death, we examined the increase in caspase activity and the occurrence of nuclear fragmentation. We found that Q79C induced caspase activation ( Figure 2c ) and nuclear fragmentation (Figure 2d and e), both of which could be attenuated by both inhibitors of Bax (BIP) and of caspases (z-VAD-fmk). Of note, the number of apoptotic cells detected by the presence of nuclear fragmentation (Figure 2d and e) was less than the net number of dead cells detected by staining of Trypan blue ( Figure 2b ) and propidium iodide (PI) (Figure 2d and e), suggesting that Q79C activates both caspase-dependent and -independent cell death pathways.
PolyQ-induced cell death is associated with an increased number of enlarged vacuoles. [19] [20] [21] We also found that Neuro2a cells with Q79C expression showed marked cytoplasmic vacuolation. BIP suppressed cytoplasmic vacuolation ( Figure  3a and b), whereas the caspase inhibitor did not. These results suggest that Q79C-induced vacuolation is Baxdependent and caspase-independent. Collectively, BIP suppressed both caspase-dependent nuclear fragmentation and caspase-independent cytoplasmic vacuolation elicited by polyQ.
Q79C expression induces Ku70 acetylation that releases Bax from Ku70. Because BIP is designed from Ku70 which prevents Bax-mediated cell death, [8] [9] [10] we examined whether Q79C had any influence on the binding between Ku70 and Bax. Q79C significantly decreased the interaction between Bax and Ku70 (Figure 4a and b) . Furthermore, we found that Q79C induced significant acetylation of Ku70 (Figure 4c ). To be noted, the acetylation of Ku70 is known to dissociate Bax and Ku70. 12 Two lysine (K) residues in Ku70, K539 and K542, are critical acetylation sites that influence Ku70-Bax binding. 12 To test whether Ku70 acetylation plays a role for the activation of Bax by polyQ, we generated acetylationresistant mutants of Ku70 and acetylation-mimicking mutants of Ku70 by substituting K539 and K542 with arginine (R) or glutamine (Q), respectively. Acetylation-resistant Ku70 mutants (K539R and K542R) 12 suppressed Q79C-induced cell death more efficiently than wild-type Ku70 (Figure 4d ). In contrast, the acetylation-mimicking Ku70 mutants (K539Q and K542Q), 12 could not suppress Q79C-induced cell death. The expression of these Ku70 mutants alone did not affect the cell viability. These results support the hypothesis that Q79C expression activates Bax, at least in part, through Ku70 acetylation. * * * Ku70 and BIP inhibit Bax conformational change induced by polyQ expression. In cells with apoptotic stimuli, Bax is known to change its conformation, and the conformational change can be detected using the 6A7 antiBax monoclonal antibody that recognizes the N-terminus of Bax by immunoprecipitation. 22, 23 The N-terminus exposure is an early step of Bax activation that occurs in the cytosol, and this conformational change is considered a prerequisite for membrane insertion of Bax at mitochondria and multimerization of Bax. [22] [23] [24] We found that Ku70 wild type and acetylation-resistant Ku70 (Ku70(K539R)), but not acetylation-mimicking Ku70 mutant (Ku70(K539Q)), inhibited the conformational change that was induced by polyQ expression (Figure 5a and b) . It was also confirmed that BIP treatment significantly blocked Bax conformational change (Figure 5c ). These results further support our hypothesis that Ku70 as well as BIP protect cells from polyQ toxicity by inhibiting Bax-mediated cell death.
Q79C binds Ku70 and histone acetyl transferase. Next, we examined how Q79C expression results in the acetylation of Ku70. The cyclic-AMP response element-binding protein (CBP) has been shown to acetylate cytosolic Ku70 in response to apoptotic stimuli. 12 Q79C is known to bind CBP in the nucleus. 4 We found that this interaction occurs in the cytosol too. We performed co-immunoprecipitation of polyQ and CBP using the cytosolic fraction and found that CBP was co-immunoprecipitated with Q79C, but not with Q22C ( Figure 6a ). In addition, we found that Ku70 binds both Q79C and Q22C in the cytosolic fraction (Figure 6b) . We further confirmed the interaction of Q79C and CBP in the cytosol fraction (Figure 6c ). These results suggest that Q79C stimulates Ku70 acetylation by bridging Ku70 and CBP (Figure 6d ). SIRT1 deacetylase and resveratrol rescue Q79C-induced cell death. The significant role of Ku70 acetylation in Q79C-induced cell death implies the possibility that the stimulation of deacetylases could reduce the polyQ toxicity. First, we examined the effect of the SIRT1 deacetylase, which has been demonstrated to deacetylate Ku70. 12 Overexpression of SIRT1 suppressed Q79C-induced cell death in Neuro-2a cells (Figure 7a and b) . Small polyphenolic molecules such as resveratrol have been found to increase the affinity of SIRT1 and its target proteins. 25 We found that resveratrol markedly suppressed the cell death induced by Q79C in the HEK293T cells and primary cortical neurons (Figure 7c-e) . We confirmed that SIRT1expression and resveratrol treatment reduced the acetylation levels of Ku70 that was increased by Q79C expression (Figure 7f ).
Discussion
We demonstrated that the inhibition of Bax by Ku70 and BIP markedly protected cells from polyQ toxicity. These results indicate that Bax plays a key role in polyQ toxicity. Our data also suggest that polyQ expression activates two different pathways of cell death. One is caspase-dependent cell death associated with nuclear fragmentation, and the other is caspase-independent cell death associated with cytoplasmic vacuolation, both of which were dramatically decreased by BIP. Cytoplasmic vacuolation has been observed in the neurons of patients with polyQ diseases. [19] [20] [21] Importantly, Bax is known to induce both caspase-independent anddependent cell death with cytoplasmic vacuolation when caspase activity is inhibited or absent. [26] [27] [28] These previous reports support our hypothesis that Bax is a key mediator of Q79C-induced cell death associated with cytoplasmic vacuolation. Recently, an elevated expression of Bax was reported in the brain of polyQ-transgenic mouse. 29, 30 We also observed that the number of pontine nucleus and microglia stained by anti-Bax 6A7-Ab in the brain section of MJD patient was significantly higher than those of normal controls (Supplementary Figure 3) . Although this result is consistent with our findings in cell culture system, there are potential limitations of such experiments using human tissue, as the conditions and timing of specimen collection cannot be strictly controlled. Further extensive investigation is needed to determine the role of Bax in MJD pathogenesis in patient brain.
The significant ability of BIP to suppress Q79C-induced cell death suggests the possibility that Q79C expression causes dissociation of Ku70 from Bax. Previously, we reported that apoptotic stimuli decreased cytosolic levels of Ku70, and that this change may be one of the mechanisms for Ku70 dissociation from Bax. 31 However, in the case of Q79C expression, the decrease of Ku70 levels was not clear ( Figure  4a and c, Ku70 input). The acetylation of Ku70 is known to be another mechanism releasing Bax from Ku70. 12 As shown in Figure 4 , Q79C induced a significant acetylation of Ku70. We also confirmed that Ku70 mutants mimicking acetylation did not suppress Q79C-induced cell death, whereas acetylationresistant Ku70 mutants rescued cells from Q79C toxicity more efficiently than Ku70 wild type. These results suggest that Ku70 acetylation is one of the major causes of Bax activation in Q79C-expressing cells.
SIRT1, one of the mammalian silent information regulator 2 (Sir2) homologues, was identified as a cell survival factor that protects cells from DNA damage. 32 SIRT1 was shown to have the activity to deacetylate several transcription factors, and through this activity, SIRT1 regulates a wide array of cellular processes for cell defense and survival under various stress conditions (reviewed by Baur and Sinclair 25 ). Recently, resveratrol, an activator of the Sir2 histone deacetylase (HDAC), 25 has been reported to rescue polyQ-induced neuronal dysfunction in Caenorhabditis elegans. 33 Similarly, in the present study, SIRT1 deacetylase and resveratrol both effectively rescued cultured cells from polyQ toxicity. We confirmed that Ku70 was acetylated by Q79C and that Ku70 was deacetylated by resveratrol and SIRT1. These observations support our hypothesis that Ku70 acetylation plays an important role in Q79C-induced cell death.
It has been hypothesized that polyQ toxicity is caused by decreased histone acetylation, as polyQ sequesters histone acetyl transferase (HAT) (e.g. CBP) from chromosomes.
2,3
The subsequent suppression of histone acetylation decreases cellular transcriptional activities, and these changes are implicated to cause polyQ toxicity. Based on this hypothesis, the maintenance of histone acetylation by HDAC inhibitors, such as trichostatin A (TSA), has been examined for the reduction of polyQ toxicity. 3, 34, 35 However, an HDAC inhibitor was recently shown to induce apoptosis in neuroblastoma cells by increasing Ku70 acetylation and promoting Bax-mediated cell death.
14 Therefore, it is plausible that HDAC inhibitors have a 'double-edge' activity in the context of After 48 h, cells were harvested and immunoprecipitation was performed using 6A7 anti-Bax monoclonal antibody polyQ toxicity; they attenuate polyQ toxicity by maintaining histone acetylation in the nucleus, but promote Bax-mediated cell death by acetylating Ku70 in the cytosol. In cultured cells, TSA can attenuate Q79C-induced cell death only at the lower doses (3-10 nM), whereas it enhances cell death at the higher doses (more than 20 nM) (Supplementary Figure 2) . Actually, the therapeutic effect of an HDAC inhibitor was observed only within a narrow range of lower doses, and the effect changed to be toxic at higher doses in polyQ transgenic mice. 35 These results suggest that the use of HDAC inhibitors in polyQ diseases requires careful consideration to avoid causing a lethal degree of Ku70 acetylation. The present study focused on the toxicity of expanded polyQ derived from the causative gene (mutated ataxin3) of MJD. Thus, further study is needed to examine whether our observation can be generally confirmed in other types of toxic polyQ such as that of Huntington's disease and spinocerebellar ataxia type 1 (SCA1).
In conclusion, we propose that Bax is a key mediator of Q79C-induced cell death and that Bax activation is mediated through acetylation of Ku70, which dissociates Bax from Ku70. Our hypothesis is based on the observation in cell culture studies, and further extensive studies using in vivo models are clearly needed. The present study suggests that 
Materials and Methods
Plasmid constructs and recombinant adenoviruses. The expression plasmids of ataxin-3 were kindly given Dr. Akira Kakizuka. The MJD1 cDNA in the plasmid was a truncated fragment including either 22 (normal, pCMX HA-Q22C) or 79 (expanded, pCMX HA-Q79C) repeats of CAG, and was hemagglutinin (HA)-fused on the N-terminus. The plasmids, pcDNA3-Bax and pCMV 2B-Flag-Ku70 have been described previously. 12 pCMV 2B-Flag-Ku70 K539R/K542R/K539Q/K542Q were generated by QuickChange Site-Directed Mutagenesis Kit from Stratagene. SIRT1 expression plasmid was generated by subcloning the coding sequence of SIRT1 cDNA (kindly provided by Dr. Shinichirou Imai) into the pcDNA3 vector (Invitrogen). Recombinant adenoviruses encoding Flag-Q79C and Flag-Q35C were constructed as described previously. Rat primary cortical neurons. Cortices were dissected from E-18 SpragueDawley rats' brains. Rat cortical neurons were plated into poly-D-lysine-coated 24-well plates. Mixed cultures were maintained in neurobasal medium. After 72 h of culture, 10 mM of cytosine arabinoside (Ara-C) was added to stop the proliferation of glial cells. After 72 h of Ara-C-treated, medium was replaced with fresh neurobasal medium.
Cell death assays. Cell death was assessed by Trypan blue exclusion, PI exclusion, LDH relase, Hoechst dye nuclear staining, MTT assay and caspase activity measurement.
For Trypan blue exclusion test, cells were collected and centrifuged for 10 min at 1000 r.p.m. The cell pellet was resuspended in 50 ml of DMEM, to which 50 ml of Trypan blue (0.4%) was added. Dead cells were counted by three independent hemocytometer counts.
LDH release from the cells into the medium was analyzed by the Cytotox 96 nonradioactive cytotoxicity assay (Promega). Cell viability of primary cortical neurons was determined by MTT assay (Chemicon) and LDH release into the medium. Nuclear condensation and membrane integrity loss were monitored by observing cells under a fluorescence microscope after application of 1 mg/ml Hoechst dye 33258 and 4 mg/ml PI. Caspase 3 activities of cells were measured with Caspase 3 Assay Kit (Sigma) in accordance with the manufacturer's instructions. For each experiment, data were obtained from three wells.
Statistical analyses for cell death were performed using the student's t-test and single-factor ANOVA, followed by Fisher's protected least-significant difference post hoc test. The results were confirmed in more than three independent experiments of all cell death analysis and Western blottings.
siRNA preparation. Sense and antisense strands of siRNA oligonucleotides were synthesized, and were then annealed at 951C for 1 min. The sense sequence of siRNA-Bax is 5 0 -CCAAGAAGCUGAGCGAGUGdTdT-3 0 and the sequence of control siRNA is 5 0 -GGUCUCGUAGACCGUGCACdTdT-3 0 .
Immunoprecipitation. For detecting the active form of Bax (Figure 5a-c) , transfected HEK293T cells in 10-cm dishes were lysed in 200 ml Chaps buffer (150 mM NaCl, 10 mM HEPES at pH 7.4 and 1.0% Chaps) containing the protease inhibitors (1 : 100 dilution of protease inhibitor Cocktail; Sigma), according to the previously reported methods. 22 After pre-clearing 200 ml of the sample with 20 ml protein A-sepharose (CL-4B, 17-0780-01; Amersham Biosciences) at 41C for 1 h, immunoprecipitation was performed by incubating 200 ml of the lysates with 2 mg of anti-Bax monoclonal antibody (clone 6A7, BD-Pharmingen) at 41C for 2 h. Immunocomplexes in 200 ml of the lysates were precipitated with 20 ml protein Asepharose. After extensive washing with buffer, beads were boiled in 40 ml Laemmli buffer, and 20 ml of the eluted proteins were analyzed by Western blotting. Western blotting analysis of pre-immunoprecipitation (input) and immunoprecipitated samples (IP) were performed with an anti-Bax polyclonal antibody (N-20, sc-493; Santa Cruz).
For detecting Bax-Ku70 interactions (Figure 4a and b) , transfected HEK293T cells in 10-cm dishes were lysed in 200 ml Chaps buffer containing the protease inhibitors. After pre-clearing 200 ml of the sample with 20 ml protein G-sepharose (4 Fast Flow, 17-0618-01; Amersham Biosciences) at 41C for 1 h, immunoprecipitation was performed by incubating 200 ml of the lysates with 2 mg of monoclonal anti-Bax antibody (B9, Santa Cruz) or 2 mg of monoclonal anti-Ku70 antibody (A9, Santa Cruz) at 41C for 2 h. Immunocomplexes in 200 ml of the lysates were precipitated with 20 mL protein G-sepharose. After extensive washing with buffer, beads were boiled in 40 ml Laemmli buffer, and 20 ml of the eluted proteins were analyzed by Western blotting. Mouse IgG was used as negative control. Western blotting analysis of pre-immunoprecipitation (input) and immunoprecipitated samples (a-Bax or a-Ku70) were performed with an anti-Ku70 polyclonal antibody (H-308, sc-9033; Santa Cruz) or an anti-Bax polyclonal antibody (N-20, sc-493; Santa Cruz).
For detecting the acetylated form of Ku70 (Figures 4c and 7f) , transfected HEK293T cells in 10-cm dishes were lysed in 200 ml 1% triton in phosphate-buffered saline containing the protease inhibitors and 5 mM TSA (Sigma). 12 After pre-clearing 200 ml of the sample with 20 ml protein G-sepharose at 41C for 1 h, immunoprecipitation was performed by incubating 200 ml of the lysates with 4 mg of anti-pan-acetyl-lysine monoclonal antibody (9681S; Cell Signaling) at 41C for 2 h. Immunocomplexes in 200 ml of the lysates were precipitated with 20 ml protein G-sepharose. After extensive washing with buffer, beads were boiled in 40 ml Laemmli buffer, and 20 ml of the eluted proteins were analyzed by Western blotting. Mouse IgG was used as negative control. Western blotting analysis of preimmunoprecipitation (input) and immunoprecipitated samples (a-Ac-K) were performed with an anti-Ku70 polyclonal antibody (H-308, sc-9033; Santa Cruz).
For detecting the interactions of HA-polyQ (Q79C) and CBP or Ku70, Ku70 and CBP (Figure 6a-c) , transfected HEK293T cells in 10-cm dishes were homogenized with 350 ml of ice-cold homogenization buffer (250 mM sucrose, 20 mM HEPES at pH 8.0, 10 mM KCl, 1.5 mM MgCl 2 , 1 mM EDTA, 1 mM EGTA, pH 7.5 and 0.1 mM PMSF) containing the protease inhibitors. The cytosolic fraction was prepared by collecting the supernatant of the centrifuged homogenate samples at 14 000 r.p.m. for 30 min at 41C. Immunoprecipitation was performed by incubating 300 ml of the lysates with 40 ml of anti-HA antibody-conjugated beads (HA-7, A2095; Sigma) or with 2 mg anti-Ku70 monoclonal antibody (A-9, sc-5309; Santa Cruz) at 41C for 2 h. Immunocomplexes of anti-Ku70 monoclonal antibody in 200 ml of the lysates were precipitated with 20 ml protein G-sepharose beads (4 Fast Flow, 17-0618-01; Amersham Biosciences). After extensive washing with buffer, beads were boiled in 40 ml Laemmli buffer, and 20 ml of the eluted proteins were analyzed by Western blotting. Western blotting analysis of pre-immunoprecipitation (input) and immunoprecipitated samples (IP) were performed with an anti-HA polyclonal antibody (HA-7, H9658; Sigma), anti-CBP polyclonal antibody (C-20, sc-583; Santa Cruz) or anti-Ku70 polyclonal antibody (H-308, sc-9033; Santa Cruz).
